Economic information and modeling report
Budget impact model
36 evidence topics · 26 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Economic information and modeling report
36 evidence topics · 26 sources